PFIZER INC Fair Value of Long-Term Debt
PFIZER INC (PFE) had Fair Value of Long-Term Debt of $37.00 billion as of 2014-06-29, per its 10-Q filed 2014-08-07.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:LongTermDebtFairValue · last filed 2014-08-07
- 2014-06-29: Long-term Debt, Fair Value $37.00B.
- 2014-03-30: Long-term Debt, Fair Value $32.60B.
- 2013-12-31: Long-term Debt, Fair Value $35.10B.
- 2013-09-29: Long-term Debt, Fair Value $36.40B.
| Period end | Long-term Debt, Fair Value |
|---|---|
| 2014-06-29 | $37.00B 10-Q · filed 2014-08-07 |
| 2014-03-30 | $32.60B 10-Q · filed 2014-05-08 |
| 2013-12-31 | $35.10B 10-Q · filed 2014-08-07 |
| 2013-09-29 | $36.40B 10-Q · filed 2013-11-08 |
| 2013-06-30 | $36.60B 10-Q · filed 2013-08-09 |
| 2013-03-31 | $37.80B 10-Q · filed 2013-05-10 |
| 2012-12-31 | $37.50B 10-K · filed 2014-02-28 |
| 2012-09-30 | $36.50B 10-Q · filed 2012-11-09 |
| 2012-07-01 | $35.50B 10-Q · filed 2012-08-09 |
| 2012-04-01 | $38.60B 10-Q · filed 2012-05-10 |
| 2011-12-31 | $40.10B 10-K · filed 2013-02-28 |
| 2011-10-02 | $40.10B 10-Q · filed 2011-11-10 |
| 2011-07-03 | $39.20B 10-Q · filed 2011-08-11 |
| 2011-04-03 | $38.70B 10-Q · filed 2011-05-12 |
| 2010-12-31 | $42.30B 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |